Magnesium sulfate and risk of hypoxic ischemic encephalopathy in a high-risk cohort

Hypoxic ischemic encephalopathy contributes to morbidity and mortality among neonates ≥ 360 weeks’ gestation. Evidence of preventative antenatal treatment is limited. Magnesium sulfate has neuroprotective properties among preterm fetuses. Hypertensive disorders of pregnancy are a risk factor for hypoxic ischemic encephalopathy and magnesium sulfate is recommended for maternal sei zure prophylaxis among patients with pre-eclampsia with severe features.

Source: American Journal of Obstetrics and Gynecology - April 2, 2024 Category: OBGYN Authors: Kathleen C. MINOR, Jessica LIU, Maurice L. DRUZIN, Yasser Y. EL-SAYED, Susan R. HINTZ, Sonia L. BONIFACIO, Stephanie A. LEONARD, Henry C. LEE, Jochen PROFIT, Scarlett D. KARAKASH Tags: Original Research: Obstetrics Source Type: research